Voice to Congress

Healthcare: Problem Statement V2.1

The U.S. does not operate a true "universal healthcare" system today. What Americans experience instead is a patchwork of employer plans, public programs, and individual-market coverage that is expensive, unstable, and administratively hostile - so the "problems with UHC in the USA" that impact Americans are really the problems caused by the lack of universality + fragmentation.

1. The harms Americans actually feel
   1. Financial Harm: paying more, getting less security
      • The U.S. spent $5.3T on health care in 2024 ($15,474 per person, 18.0% of GDP) - yet still leaves millions uninsured and many more underinsured.
      • For working families, job-based coverage is increasingly unaffordable: average family premium ~$26,993/year (2025) with workers paying ~$6,850 out of pocket just for premiums (before deductibles/copays).
      • Medical debt remains widespread and destabilizing: 41% of adults reported some form of health care debt in 2022 (broad definition including debt on cards/loans/family).
        o Separate household-data research finds 36% of U.S. households had medical debt in 2024.
      Impact on the People: bills that do not match expectations, postponed care, drained savings, delayed retirement, delayed home ownership, and chronic stress.
   2. Coverage Harm: people fall through cracks-and many live on the edge
      • In 2024, 27.2 million people (8.2%) were uninsured; among adults 18-64, 11.6% were uninsured.
      Impact on the People: a job change, divorce, paperwork glitch, or income swing can mean losing access to doctors, medications, and continuity of care.
   3. Care delays and denials: "insured" is Not the same as "treated".
      • Prior authorization is a major driver of delayed care. In a national physician survey, 94% reported that prior authorization delays access to necessary care, and 24% reported it led to a serious adverse event for a patient (including hospitalization, permanent impairment, or death).
      • The HHS Office of Inspector General found that Medicare Advantage organizations sometimes denied or delayed services that met Medicare coverage rules-raising beneficiary access concerns.
      Impact on the People: cancer workups, imaging, surgeries, specialty referrals, and even basic therapies can get stuck in weeks of bureaucracy-or never happen.
   4. Geographic Harm: access depends on where you live
      • Rural hospital closures and conversions have been substantial; the UNC Sheps Center for Health Services Research reports 152 rural hospital closures/conversions since 2010 (with definitions separating complete closures vs. converted closures).
      Impact on the People: longer drives for emergency care, maternity services deserts, fewer specialists, and weaker local economies.
   5. Drug-price Harm: Americans pay far more for the same medicines
      • RAND Corporation estimates U.S. prescription drug prices average 2.78x those in peer countries (2022 data).
      Impact on the People: Rationing medications, worsening chronic disease, avoidable complications, and higher insurance premiums.
   6. Workforce/capacity Harm: even "coverage" can not fix shortages by itself
      • Association of American Medical Colleges projects a physician shortage of up to 86,000 by 2036 under multiple scenarios.
      Impact on the People: longer waits, delayed diagnoses, and overloaded primary care—especially in rural and low-income communities.
   7. Equity Harm: the system performs worst where it should protect people most
      • The Commonwealth Fund reports the U.S. ranks lowest overall among peer countries on measures including access, equity, and outcomes-despite the highest spending.
      • It also documents large state-by-state differences in access, affordability, outcomes, and equity.
      What that means for people: your income, race, and ZIP code remain powerful predictors of whether you get timely care—and whether you live longer.
2. Root causes (why these harms persist)
   1. Fragmented financing and eligibility (multiple payers + different rules) –> gaps, churn, and administrative burden.
   2. Weak price discipline in key markets (hospital prices, specialist pricing, drugs) → spending rises faster than wages.
   3. Administrative complexity as a business model (billing overhead, prior auth, denial management) –> time costs, burnout, delayed care.
   4. Coverage churn baked into program design (renewals, redeterminations, paperwork) –> interruptions in meds and care.
   5. Capacity constraints (workforce shortages, rural infrastructure fragility) –> coverage ≠ access.
3. What Top-Ranked Countries Actually Do Differently

   "Universal coverage," "strong primary care," and "cost control" are the headlines. Underneath them are specific, concrete mechanisms – and the U.S. system is missing most of them, not by accident but by design choices made decades ago.

   1. Coverage is automatic, not applied for
      • Services Australia automatically enrolls newborns in Medicare through birth registration – no separate application – funded through a 2% income tax levy collected automatically at tax time, not a premium someone shops for and buys.
      • The Netherlands' Health Insurance Act (Zorgverzekeringswet) legally requires every insurer to accept every applicant; medical underwriting and denial for pre-existing conditions are prohibited, and the government pays the premium directly for every child under 18.
      • Germany's statutory health insurance system (Gesetzliche Krankenversicherung) automatically assigns employees below an income threshold to a sickness fund, and covers family members free under the primary insured's contribution – no per-dependent charge.
      Impact on the People: coverage is tied to a status people already have (born here, employed here, resident here) that triggers enrollment automatically. In the U.S., coverage is tied to a transaction someone has to complete correctly, and re-complete whenever life changes.
   2. Coverage doesn't reset when life changes
      • Peer-country coverage is attached to one stable fact: residency or citizenship. It does not depend on age, income, employment, or marital status.
      • The U.S. instead runs several separate eligibility systems side by side – Medicare (age), Medicaid (income), employer coverage (job status), TRICARE/VA (military status) – each with its own rules. The U.S. Department of Labor's own HIPAA and COBRA continuation-coverage rules exist specifically to patch the gaps this fragmentation creates when a job change, divorce, or income swing knocks someone out of one system before they're safely inside another.
      Impact on the People: this is the fragmentation problem already described above, but peer systems avoid it structurally by design – there is only one status to maintain, not several.
   3. Primary care is a guaranteed relationship, not a market search
      • The American Board of Family Medicine's review of UK primary care documents that GP registration is required to access most NHS services – every resident has an assigned point of contact, and that GP coordinates referrals to specialists.
      • OECD physician-density data shows Germany at roughly 4.7 physicians per 1,000 population, against roughly 2.7 per 1,000 in the U.S.
      Impact on the People: the U.S. gap is not only a shortage of doctors – it is the absence of any mechanism that assigns a primary care relationship to a person at all, on top of that shortage.
   4. Someone negotiates drug prices on the public's behalf
      • The UK's National Institute for Health and Care Excellence (NICE) runs a binding cost-effectiveness assessment that caps what the NHS will pay, as described in the AMA Journal of Ethics' review of international drug pricing strategies.
      • Germany's AMNOG system, described in a PMC-published pharmaceutical pricing review, ties price to proven added clinical benefit over existing treatments; without it, a drug is capped at a reference price.
      • The Commonwealth Fund's 2026 review of international drug pricing found that Canada's provinces negotiate jointly through the pan-Canadian Pharmaceutical Alliance rather than separately, and that Australia's Pharmaceutical Benefits Scheme secures one national price for community medicines.
      • By contrast, a WHO Bulletin analysis of U.S. universal-coverage challenges notes that current U.S. law explicitly prohibits creating a NICE-equivalent cost-effectiveness institute – a legal bar written into the ACA itself, not simply a policy that hasn't been tried.
      Impact on the People: RAND Corporation's finding (already cited above) that Americans pay 2.78x peer-country drug prices is not a mystery – it is the predictable result of thousands of separate U.S. payers each negotiating alone against a single manufacturer, instead of one buyer with real leverage.
   5. Administrative simplicity is measured and managed, not aspirational
      • Health economist Tsung-Mei Cheng's analysis (Milken Institute Review; Physicians for a National Health Program) documents that Taiwan's single-payer National Health Insurance runs on administrative overhead of roughly 1-2% of total spending – one national IT platform, one claims format, a 24-hour claims-submission requirement, one benefit package for everyone.
      • The same analysis reports that a major U.S. commercial insurer diverted 19.1% of premiums to administration, marketing, and profit in a recent year.
      Impact on the People: this is the clearest number in this entire section. Taiwan's 1-2% is not a theoretical target – it is a 25-plus-year operating track record.
   6. Out-of-pocket exposure is capped and exempted for the people who need care most
      • A ten-country comparative study of out-of-pocket cost-sharing (PMC) found that France caps cost-sharing per service category (roughly $54, additive) with full exemptions for low-income people, anyone with a chronic illness, and pregnant women past five months, and that Germany layers income-based exemption thresholds on top of its cost-sharing rules.
      Impact on the People: the design goal isn't just "cheaper care" – it is structural protection targeted at the population most likely to need care repeatedly, which is exactly the population medical debt concentrates in.
   7. Rural access gaps are closed with measured, targeted incentives
      • A natural-experiment study of Australia's rural bulk-billing incentive increase found a measured 9.0% rise in free rural GP visits and a 13.0% reduction in out-of-pocket cost per rural visit, closing an estimated third to three-quarters of the rural-urban access gap.
      Impact on the People: this is not a hypothetical fix – it is a policy with a documented, measured before-and-after effect.
   8. The physician pipeline isn't artificially capped
      • Medical Economics' analysis of the physician workforce crisis finds that the core U.S. bottleneck is not medical school enrollment – it is residency (GME) capacity, held down for decades by a Medicare-funding cap on the number of training slots.
      • A comparative review of German and U.S. medical education (published via the German Medical Science portal) documents that Germany shortens the entire pipeline structurally: medical training begins right after high school in an integrated six-year program, rather than a four-year bachelor's degree followed by a separate four-year medical degree.
      Impact on the People: expanding medical school seats alone will not fix this – the residency bottleneck and the pipeline length are two different levers, and a workforce plan needs to address both.

   None of this is destiny. Every mechanism above is a specific, replicable policy choice – not a feature of national character or wealth. The U.S. spends more than enough to afford any of them; it has simply chosen not to build them.

4. What these problems imply as UHC design requirements
   If a U.S. "universal" plan does not meet these, it will reproduce today's pain under a new label:
   • Automatic enrollment + no gaps (coverage is the default, not an application).
   • Portability (job change/divorce/income change does not break your care).
   • Continuous eligibility rules (especially for children and low-income adults) to reduce churn.
   • Standardized/admin-minimized operations: one eligibility interface, standardized claims, strong electronic standards, and strict timelines.
   • Prior authorization reform or replacement (narrow scope, real-time decisions, transparency, independent review).
   • Drug price discipline aligned with peer-country purchasing power.
   • Rural stabilization (facility support + transport + workforce incentives).
   • Workforce expansion plan (GME, loan repayment, scope-of-practice alignment, primary-care capacity).
   • Household protection: cap out-of-pocket exposure, reduce surprise billing risk, and eliminate medical-debt drivers.
5. Suggested "success KPIs" (testable, people-centered)
   Use these as acceptance criteria for a UHC transition:
   • Uninsured rate and underinsured rate (trend + subgroup equity).
   • Household medical debt prevalence and past-due medical bills.
   • Average family premium-equivalent burden (as % of median household income) and out-of-pocket max exposure.
   • Median time-to-appointment for primary care, mental health, and key specialties (by county).
   • Prior authorization denial rate, turnaround time, appeal reversal rate, and adverse-event reports.
   • Rural access metrics (distance/time to ED, L&D availability, closure risk).
   • Per-capita spending growth vs. wage growth (and administrative cost share).